Mirum Pharmaceuticals, Inc.: cashflow_financing
| Value | {"amount": 18104000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-03-31 |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6138cc2a-8f62-40d5-ad1d-9dc23258d267
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-007812Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/cashflow-financing/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6138cc2a-8f62-40d5-ad1d-9dc23258d267
History
- no predecessors — first report